Latest filing published 25 Feb 2019 for Meridian Bioscience INC, €6,257.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -49.4%Entry 51.99 · Close at T+365 26.30
- -69.4%Entry 101.40 · Close at T+365 31.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lawrence Baldini: trading record in brief
This profile gathers the share dealings of Lawrence Baldini in Meridian Bioscience Inc. Over a trading history stretching from 17 July 2006 to 15 December 2018, the count stands at 76 filings.
Both buying and selling appear: 4 purchases worth €738k, against 22 sales worth €3.0M. On balance, insiders were net sellers of €2.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 30 share grants and 11 option exercises.
A typical purchase (the median) is worth €94k.
The latest filing, published on 25 February 2019, reports a share grant of €6,257 in Meridian Bioscience Inc. The last purchase on record was published on 30 January 2017, which is 3,569 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lawrence Baldini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 407 shares@ US$17.471.0% of flowCommon StockSEC:0001127602-19-007866:0
- 12,500 shares0Common StockSEC:0001127602-18-033648:0
- 2,818 shares@ US$19.156.9% of flowCommon StockSEC:0001127602-18-033648:1
- 25,225 shares@ US$19.3562.0% of flowCommon StockSEC:0001127602-18-032958:0
- 9,876 shares@ US$19.5524.7% of flowCommon StockSEC:0001127602-18-032958:1
- 7,500 shares0Common StockSEC:0001127602-17-031877:0
- 10,000 shares0Common StockSEC:0001127602-17-031877:1
- 3,080 shares@ US$14.624.6% of flowCommon StockSEC:0001127602-17-031650:0
- 4,000 shares@ US$12.705.6% of flowCommon StockSEC:0001127602-17-002766:0Canonical exit: 26 Apr 2017 (T+90)
- 10,000 shares0Common StockSEC:0001127602-16-066790:0
- 10,000 shares0Common StockSEC:0001127602-16-066790:1
- 10,000 shares0Common StockSEC:0001127602-16-066790:2
- 2,567 shares@ US$16.274.4% of flowCommon StockSEC:0001127602-16-066572:0
- 4,900 shares@ US$16.008.3% of flowCommon StockSEC:0001127602-16-066214:0Canonical exit: 1 Feb 2017 (T+90)
- 225 shares0Common StockSEC:0001127602-16-049549:0
- 2,558 shares@ US$20.11Common StockSEC:0001127602-15-031178:0
- 10,000 shares0Common StockSEC:0001127602-15-030532:0
- 10,000 shares0Common StockSEC:0001127602-15-030532:1
- 9,000 shares0Common StockSEC:0001127602-15-030532:2
- 2,566 shares@ US$16.84Common StockSEC:0001127602-14-032112:0
- 9,000 shares0Common StockSEC:0001127602-14-031663:0
- 9,000 shares0Common StockSEC:0001127602-14-031663:1
- 9,000 shares0Common StockSEC:0001127602-14-031663:2
- 4,926 shares@ US$24.26Common StockSEC:0001127602-13-032412:0
- 9,000 shares0Common StockSEC:0001127602-13-031060:0
25 of 70 declarations